These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24255771)

  • 1. Cytokeratin-based CTC counting unrelated to clinical follow up.
    Chinen LT; de Carvalho FM; Rocha BM; Aguiar CM; Abdallah EA; Campanha D; Mingues NB; de Oliveira TB; Maciel MS; Cervantes GM; Dettino AL; Soares FA; Paterlini-Bréchot P; Fanelli MF
    J Thorac Dis; 2013 Oct; 5(5):593-9. PubMed ID: 24255771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
    Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
    J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analogous detection of circulating tumor cells using the AccuCyte
    van der Toom EE; Groot VP; Glavaris SA; Gemenetzis G; Chalfin HJ; Wood LD; Wolfgang CL; de la Rosette JJMCH; de Reijke TM; Pienta KJ
    Prostate; 2018 Mar; 78(4):300-307. PubMed ID: 29285777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy.
    Zhang D; Zhao L; Zhou P; Ma H; Huang F; Jin M; Dai X; Zheng X; Huang S; Zhang T
    Cancer Cell Int; 2017; 17():6. PubMed ID: 28070168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances and prospects in the isolation by size of epithelial tumor cells (ISET) methodology.
    Ma YC; Wang L; Yu FL
    Technol Cancer Res Treat; 2013 Aug; 12(4):295-309. PubMed ID: 23448577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of circulating tumor cells and evaluation of epithelial-mesenchymal transition patterns of circulating tumor cells in ovarian cancer.
    Jie XX; Zhang M; Du M; Cai QQ; Cong Q; Xu CJ; Zhang XY
    Transl Cancer Res; 2022 Aug; 11(8):2636-2646. PubMed ID: 36093536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker.
    Khoja L; Backen A; Sloane R; Menasce L; Ryder D; Krebs M; Board R; Clack G; Hughes A; Blackhall F; Valle JW; Dive C
    Br J Cancer; 2012 Jan; 106(3):508-16. PubMed ID: 22187035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method.
    Hofman V; Ilie MI; Long E; Selva E; Bonnetaud C; Molina T; Vénissac N; Mouroux J; Vielh P; Hofman P
    Int J Cancer; 2011 Oct; 129(7):1651-60. PubMed ID: 21128227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
    Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
    J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of circulating tumor cells and microemboli to predict diagnosis and prognosis in diffuse glioma.
    Qi Y; Xu Y; Yan T; Xiong W; Zhu X; Sun Q; Deng G; Yuan F; Ye L; Hu P; Liu B; Zhang S; Deng S; He Y; Wu G; Ye Q; Chen Q
    J Neurosurg; 2024 Apr; ():1-11. PubMed ID: 38608304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Tumor Cell Analyses in Patients With Esophageal Squamous Cell Carcinoma Using Epithelial Marker-Dependent and -Independent Approaches.
    Li H; Song P; Zou B; Liu M; Cui K; Zhou P; Li S; Zhang B
    Medicine (Baltimore); 2015 Sep; 94(38):e1565. PubMed ID: 26402816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch
    Tamminga M; Andree KC; Hiltermann TJN; Jayat M; Schuuring E; van den Bos H; Spierings DCJ; Lansdorp PM; Timens W; Terstappen LWMM; Groen HJM
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32272669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
    Zheng X; Fan L; Zhou P; Ma H; Huang S; Yu D; Zhao L; Yang S; Liu J; Huang A; Cai C; Dai X; Zhang T
    Transl Oncol; 2017 Jun; 10(3):431-441. PubMed ID: 28448959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
    Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
    Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two detection systems for circulating tumor cells among patients with renal cell carcinoma.
    Bai M; Zou B; Wang Z; Li P; Wang H; Ou Y; Cui K; Bian J; Li S; Xu X
    Int Urol Nephrol; 2018 Oct; 50(10):1801-1809. PubMed ID: 30120680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
    Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF
    Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
    Abdallah EA; Braun AC; Flores BCTCP; Senda L; Urvanegia AC; Calsavara V; Fonseca de Jesus VH; Almeida MFA; Begnami MD; Coimbra FJF; da Costa WL; Nunes DN; Dias-Neto E; Chinen LTD
    Oncologist; 2019 Sep; 24(9):e854-e863. PubMed ID: 30846515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
    Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
    PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between circulating tumor cell phenotyping and 18F-fluorodeoxyglucose positron emission tomography uptake in non-small cell lung cancer.
    Bian J; Yan K; Liu N; Xu X
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2621-2630. PubMed ID: 32661602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTC-5: A novel digital pathology approach to characterise circulating tumour cell biodiversity.
    Ffrench B; Kashdan E; Huang Y; Spillane CD; Cocchiglia S; Charmsaz S; Varešlija D; O'Brien C; Scholz D; Martin C; Gallagher M; Brooks DA; Brooks RD; Selemidis S; Gleeson N; AbuSaadeh F; O'Riain C; Kamran W; Flavin R; Young L; O'Toole SA; O'Leary JJ
    Heliyon; 2023 Jan; 9(1):e13044. PubMed ID: 36747925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.